Status:
COMPLETED
Evaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver Disease
Lead Sponsor:
University of Western Ontario, Canada
Conditions:
Non-alcoholic Fatty Liver Disease
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the use of phlebotomy (blood taking)as a treatment for patients with non-alcoholic fatty liver disease.
Detailed Description
In this study phlebotomy will be evaluated as a therapy for non-alcoholic fatty liver disease (NAFLD), a common and important cause of liver disease. Phlebotomy has been used for many years in the tre...
Eligibility Criteria
Inclusion
- Patients 18y or older
- Diagnosis of Non-alcoholic Fatty Liver Disease
Exclusion
- Unable or unwilling to provide informed consent
- Alcohol consumption of \>10g/day for women and \>20g/day for men
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00641524
Start Date
January 1 2009
End Date
December 1 2011
Last Update
May 13 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
London Health Sciences Centre
London, Ontario, Canada, N6A 5A5